Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieselot van Erven

Showing results (81-90 of 120) with videos related to

Pageof 12
Sort By:
The American Journal of Cardiology|June 29, 2004
Effect of left ventricular remodeling after cardiac resynchronization therapy on frequency of ventricular arrhythmiasPhilippine Kiès, Jeroen J Bax, Sander G Molhoek, et al.
Circulation|March 8, 2006
Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loopsPaul Steendijk, Sven A Tulner, Jeroen J Bax, et al.
Diabetes Care|December 11, 2012
Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapyUlas Höke, Joep Thijssen, Rutger J van Bommel, et al.
Journal of the American College of Cardiology|November 19, 2011
Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonrespondersJoep Thijssen, C Jan Willem Borleffs, Victoria Delgado, et al.
European Heart Journal|June 8, 2011
Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approachJoep Thijssen, C Jan Willem Borleffs, Johannes B van Rees, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 18, 2024
Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of CardiologyAnne-Lotte C J van der Lingen, Tom E Verstraelen, Lieselot van Erven, et al.
JACC. Heart Failure|January 9, 2026
Clinical Impact of Device-Based Multisensory Monitoring in Heart Failure: A Propensity-Matched Study From the NetherlandsUgur Aslan, Bert A C Zwaenepoel, Bas Kirchhof, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 9, 2010
Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI studyJael Z Atary, C Jan Willem Borleffs, Su San Liem, et al.
Heart Rhythm|December 13, 2006
Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patientsMarcelle D Smit, Pascal F H M Van Dessel, Wybe Nieuwland, et al.
Pacing and Clinical Electrophysiology : PACE|September 4, 2013
Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registryJoep Thijssen, M Elske van den Akker van Marle, C Jan Willem Borleffs, et al.
Pageof 12

Showing results (81-90 of 120) with videos related to

Sort By:
Pageof 12
The American Journal of Cardiology|June 29, 2004
Effect of left ventricular remodeling after cardiac resynchronization therapy on frequency of ventricular arrhythmiasPhilippine Kiès, Jeroen J Bax, Sander G Molhoek, et al.
Circulation|March 8, 2006
Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loopsPaul Steendijk, Sven A Tulner, Jeroen J Bax, et al.
Diabetes Care|December 11, 2012
Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapyUlas Höke, Joep Thijssen, Rutger J van Bommel, et al.
Journal of the American College of Cardiology|November 19, 2011
Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonrespondersJoep Thijssen, C Jan Willem Borleffs, Victoria Delgado, et al.
European Heart Journal|June 8, 2011
Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approachJoep Thijssen, C Jan Willem Borleffs, Johannes B van Rees, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|April 18, 2024
Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of CardiologyAnne-Lotte C J van der Lingen, Tom E Verstraelen, Lieselot van Erven, et al.
JACC. Heart Failure|January 9, 2026
Clinical Impact of Device-Based Multisensory Monitoring in Heart Failure: A Propensity-Matched Study From the NetherlandsUgur Aslan, Bert A C Zwaenepoel, Bas Kirchhof, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|January 9, 2010
Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI studyJael Z Atary, C Jan Willem Borleffs, Su San Liem, et al.
Heart Rhythm|December 13, 2006
Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patientsMarcelle D Smit, Pascal F H M Van Dessel, Wybe Nieuwland, et al.
Pacing and Clinical Electrophysiology : PACE|September 4, 2013
Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registryJoep Thijssen, M Elske van den Akker van Marle, C Jan Willem Borleffs, et al.
Pageof 12